Device Development for Long-Acting Injectables

Walter joined Gilead Sciences in 2017 and has supported development of long-acting injectables for HIV, including the SUNLENCA® vial kit. During his tenure at Gilead, Walter has developed novel devices, including high-powered injectors, as well as custom primary containers to enable delivery of highly viscous formulations. Prior to Gilead, Walter worked as a device engineer at Genentech while completing his master’s degree in Mechanical Engineering at Stanford University.